Press Release March 5, 2022U.S. Food and Drug Administration Approves Opdivo® (nivolumab) with Chemotherapy as Neoadjuvant Treatment for Certain Adult Patients with Resectable Non-Small Cell Lung Cancer 0 0 Share
Press Release March 5, 2022BETMGM SIGNS EDMONTON OILERS CAPTAIN CONNOR MCDAVID AS BRAND AMBASSADOR 0 0 Share
Press Release March 5, 2022INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Verra Mobility Corporation (VRRM) on Behalf of Investors 0 0 Share
Press Release March 5, 2022EDU Investors Have Opportunity to Lead New Oriental Education & Technology Group Inc. Securities Fraud Lawsuit 0 0 Share
Press Release March 5, 2022Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 0 0 Share
Press Release March 5, 2022The Law Offices of Frank R. Cruz Continues Its Investigation of Verra Mobility Corporation (VRRM) on Behalf of Investors 0 0 Share
Press Release March 5, 2022HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Bumble (BMBL) Investors to Filing of Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys 0 0 Share
Press Release March 5, 2022BUMBLE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bumble Inc. - BMBL 0 0 Share
Press Release March 4, 2022Array Technologies, Inc. Receives Notification from Nasdaq Related to Delayed Annual Report on Form 10-K 0 0 Share
